GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,221,000 | +8.4% | 533,092 | +9.7% | 0.45% | +10.6% |
| Q4 2021 | $21,426,000 | +16.7% | 485,853 | +1.1% | 0.41% | +8.5% |
| Q3 2021 | $18,364,000 | +0.5% | 480,614 | +4.7% | 0.38% | +1.6% |
| Q2 2021 | $18,273,000 | +16.3% | 458,900 | +4.2% | 0.37% | +4.2% |
| Q1 2021 | $15,718,000 | -5.4% | 440,391 | -2.4% | 0.35% | -13.7% |
| Q4 2020 | $16,607,000 | -1.1% | 451,288 | +1.2% | 0.41% | -10.3% |
| Q3 2020 | $16,784,000 | -15.9% | 445,906 | -8.8% | 0.46% | -20.1% |
| Q2 2020 | $19,950,000 | +8.8% | 489,094 | +1.0% | 0.57% | -7.3% |
| Q1 2020 | $18,340,000 | -50.4% | 484,028 | -38.4% | 0.62% | -35.4% |
| Q4 2019 | $36,947,000 | +12.0% | 786,283 | +1.7% | 0.96% | +4.4% |
| Q3 2019 | $32,982,000 | +9.5% | 772,770 | +2.6% | 0.92% | +7.8% |
| Q2 2019 | $30,129,000 | -3.6% | 752,846 | +0.7% | 0.85% | -8.8% |
| Q1 2019 | $31,248,000 | +11.4% | 747,743 | +1.9% | 0.93% | -2.0% |
| Q4 2018 | $28,048,000 | +17.6% | 734,059 | +23.6% | 0.95% | +30.5% |
| Q3 2018 | $23,859,000 | -0.0% | 593,953 | +0.3% | 0.73% | -4.1% |
| Q2 2018 | $23,870,000 | +2.6% | 592,157 | -0.6% | 0.76% | +3.4% |
| Q1 2018 | $23,268,000 | +27.5% | 595,540 | +15.7% | 0.73% | +29.5% |
| Q4 2017 | $18,251,000 | -19.0% | 514,550 | -7.3% | 0.57% | -22.5% |
| Q3 2017 | $22,539,000 | -25.6% | 555,138 | -21.0% | 0.73% | -29.8% |
| Q2 2017 | $30,298,000 | +14.6% | 702,652 | +12.1% | 1.04% | +11.4% |
| Q1 2017 | $26,432,000 | +16.8% | 626,948 | +6.7% | 0.94% | +14.1% |
| Q4 2016 | $22,629,000 | -4.7% | 587,608 | +6.8% | 0.82% | -5.6% |
| Q3 2016 | $23,738,000 | +20.8% | 550,382 | +21.4% | 0.87% | +11.3% |
| Q2 2016 | $19,648,000 | +14.9% | 453,345 | +7.5% | 0.78% | +8.9% |
| Q1 2016 | $17,097,000 | +9.9% | 421,630 | +9.3% | 0.72% | +4.5% |
| Q4 2015 | $15,559,000 | +14.4% | 385,604 | +9.0% | 0.69% | +15.7% |
| Q3 2015 | $13,606,000 | -0.9% | 353,866 | +7.4% | 0.59% | +14.0% |
| Q2 2015 | $13,724,000 | +174.7% | 329,511 | +204.4% | 0.52% | +187.3% |
| Q1 2015 | $4,996,000 | +19.8% | 108,266 | +10.9% | 0.18% | +23.1% |
| Q4 2014 | $4,171,000 | -3.6% | 97,596 | +3.7% | 0.15% | -5.8% |
| Q3 2014 | $4,326,000 | +1009.2% | 94,107 | +1189.1% | 0.16% | +1014.3% |
| Q2 2014 | $390,000 | 0.0% | 7,300 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $390,000 | -5.8% | 7,300 | -5.8% | 0.01% | -6.7% |
| Q4 2013 | $414,000 | +6.4% | 7,747 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $389,000 | +0.5% | 7,747 | 0.0% | 0.02% | -6.2% |
| Q2 2013 | $387,000 | – | 7,747 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |